ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,731,532 | -11.4% | 63,800 | +0.3% | 0.02% | -7.4% |
| Q2 2023 | $1,955,064 | -18.2% | 63,600 | -4.1% | 0.03% | -22.9% |
| Q1 2023 | $2,388,789 | -8.8% | 66,300 | 0.0% | 0.04% | -16.7% |
| Q4 2022 | $2,620,176 | -0.7% | 66,300 | +0.9% | 0.04% | -4.5% |
| Q3 2022 | $2,639,000 | -4.1% | 65,700 | +0.3% | 0.04% | 0.0% |
| Q2 2022 | $2,753,000 | +21.9% | 65,500 | +12.9% | 0.04% | +46.7% |
| Q1 2022 | $2,259,000 | -3.9% | 58,000 | -1.7% | 0.03% | +3.4% |
| Q4 2021 | $2,351,000 | +10.6% | 59,000 | +0.3% | 0.03% | 0.0% |
| Q3 2021 | $2,125,000 | -15.8% | 58,800 | -4.5% | 0.03% | -12.1% |
| Q2 2021 | $2,525,000 | -5.7% | 61,600 | +0.3% | 0.03% | -10.8% |
| Q1 2021 | $2,678,000 | +153.6% | 61,400 | +191.0% | 0.04% | +146.7% |
| Q4 2020 | $1,056,000 | – | 21,100 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $106,824,000 | 67.12% |
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $269,465,000 | 56.37% |
| Vantage Consulting Group Inc | 4,601,152 | $183,355,000 | 49.30% |
| Indie Asset Partners, LLC | 805,982 | $32,118,000 | 23.31% |
| HARVARD MANAGEMENT CO INC | 3,464,990 | $138,080,000 | 12.96% |
| Brown University | 621,759 | $24,777,000 | 6.04% |
| Overbrook Management Corp | 729,125 | $29,056,000 | 5.86% |
| Bleichroeder LP | 824,033 | $32,838,000 | 5.13% |
| Geo Capital Gestora de Recursos Ltd | 200,692 | $7,998,000 | 3.81% |
| Lagoda Investment Management, L.P. | 140,435 | $5,596,000 | 2.65% |